Výsledky vyhľadávania - "Naphthyridines adverse effects"

First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting

Autori: Susanne B. Nicholas Ricardo Correa-Rotter Nihar R. Desai a ďalší

Zdroj: J Nephrol
Journal of Nephrology, vol 37, iss 8

Predmety: Male, ddc:610, Type 2 diabetes, Finerenone, Middle Aged, Non-interventional study, Female [MeSH], Aged [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Naphthyridines/therapeutic use [MeSH], Humans [MeSH], Prospective Studies [MeSH], Mineralocorticoid Receptor Antagonists/therapeutic use [MeSH], Treatment Outcome [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Middle Aged [MeSH], Renal Insufficiency, Chronic/complications [MeSH], Original Article, Mineralocorticoid Receptor Antagonists/adverse effects [MeSH], Male [MeSH], Naphthyridines/adverse effects [MeSH], Chronic kidney disease, Diabetic Nephropathies/drug therapy [MeSH], Hyperkalemia/chemically induced [MeSH], Treatment Outcome, Diabetes Mellitus, Type 2, Diabetes Mellitus, Humans, Hyperkalemia, Female, Diabetic Nephropathies, Renal Insufficiency, Prospective Studies, Chronic, Naphthyridines, Renal Insufficiency, Chronic, Type 2, Mineralocorticoid Receptor Antagonists, Aged

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39340711
https://repository.publisso.de/resource/frl:6504825
https://escholarship.org/content/qt9g65h48z/qt9g65h48z.pdf
https://escholarship.org/uc/item/9g65h48z
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/39683
https://opus.bibliothek.uni-wuerzburg.de/files/39683/40620_2024_Article_2070.pdf
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-396835
https://doi.org/10.1007/s40620-024-02070-y

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

Autori: Pitt, Bertram Filippatos, Gerasimos Agarwal, Rajiv a ďalší

Prispievatelia: Pitt, Bertram Filippatos, Gerasimos Agarwal, Rajiv a ďalší

Zdroj: Pitt, B, Filippatos, G, Agarwal, R, Anker, S D, Bakris, G L, Rossing, P, Joseph, A, Kolkhof, P, Nowack, C, Schloemer, P, Ruilope, L M & FIGARO DKD Investigators 2021, ' Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes ', New England Journal of Medicine, vol. 385, pp. 2252-2263 . https://doi.org/10.1056/NEJMoa2110956

Predmety: Male, Renal Insufficiency, Chronic/complications, Enfermedad cardiovascular, Naphthyridines/adverse effects, General & Internal, MELLITUS, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Mineralocorticoid Receptor Antagonists/adverse effects, General & Internal Medicine, Albuminuria, Humans, Naphthyridines, Renal Insufficiency, Chronic, Sistema cardiovascular, Aged, Mineralocorticoid Receptor Antagonists, Proportional Hazards Models, RISK, OUTCOMES, Science & Technology, Fallo renal crónico, Medicamento, Cardiovascular Diseases/epidemiology, Diabetes Mellitus, Type 2/complications, MORTALITY, Middle Aged, CHRONIC HEART-FAILURE, 3. Good health, Hospitalization, Diabetes mellitus tipo 2, Albuminuria/etiology, Diabetes Mellitus, Type 2, Cardiovascular Diseases, SAFETY, Medicine, Female, Life Sciences & Biomedicine

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34449181
https://pubmed.ncbi.nlm.nih.gov/34449181/
https://www.ncbi.nlm.nih.gov/pubmed/34449181
https://www.nejm.org/doi/full/10.1056/NEJMoa2110956
https://curis.ku.dk/ws/files/290115527/Cardiovascular_Events_with_Finerenone.pdf
https://hdl.handle.net/11268/10509
https://biblio.vub.ac.be/vubir/cardiovascular-events-with-finerenone-in-kidney-disease-and-type-2-diabetes(7a510e54-9544-43d5-9208-379a3c1aad07).html

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study

Autori: File, Thomas Mandell, Lionel Tillotson, Glenn a ďalší

Zdroj: Journal of Antimicrobial Chemotherapy. 60:112-120

Predmety: Adult, Male, Anti-bacterial agents - adverse effects, Double-blind method, Adolescent, Fluoroquinolones - administration & dosage, Fluoroquinolones - therapeutic use, Anti-bacterial agents - administration & dosage, Fluoroquinolones - adverse effects, Drug Administration Schedule, Anti-bacterial agents - therapeutic use, Double-Blind Method, 80 and over, bacterial - drug therapy, Pneumonia, Bacterial, Humans, Community-acquired infections - drug therapy, Treatment outcome, Naphthyridines, Middle aged, Streptococcus pneumoniae - isolation & purification, Aged, pneumococcal - microbiology, Aged, 80 and over, Drug administration schedule, Pneumonia, Naphthyridines - administration & dosage, Middle Aged, Pneumonia, Pneumococcal, Naphthyridines - adverse effects, Gemifloxacin, Anti-Bacterial Agents, 3. Good health, Community-Acquired Infections, Streptococcus pneumoniae, Treatment Outcome, Community-acquired infections - microbiology, Naphthyridines - herapeutic use, pneumococcal - drug therapy, Female, bacterial - microbiology, Fluoroquinolones

Prístupová URL adresa: https://academic.oup.com/jac/article-pdf/60/1/112/2169296/dkm119.pdf
https://pubmed.ncbi.nlm.nih.gov/17537866
https://academic.oup.com/jac/article-abstract/60/1/112/728925
http://jac.oxfordjournals.org/content/60/1/112.full
https://europepmc.org/article/MED/17537866
http://academic.oup.com/jac/article/60/1/112/728925/Gemifloxacin-once-daily-for-5-days-versus-7-days
https://www.ncbi.nlm.nih.gov/pubmed/17537866
https://pubmed.ncbi.nlm.nih.gov/17537866/

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial

Autori: Bakris, George L Agarwal, Rajiv Chan, Juliana C. a ďalší

Zdroj: JAMA. 314:884

Predmety: Mineralocorticoid receptor antagonists - therapeutic use, Male, 0301 basic medicine, Dose-response relationship, Administration, Oral, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, oral, Diabetes mellitus, 0302 clinical medicine, Diabetic Nephropathies, Analysis of variance, Middle aged, Diabetic nephropathies - physiopathology, Mineralocorticoid Receptor Antagonists, 2. Zero hunger, Diabetic nephropathies - ethnology, Incidence, Potassium - blood, drug, Middle Aged, 16. Peace & justice, 3. Good health, Angiotensin-converting enzyme inhibitors - therapeutic use, type 2 - complications, Creatinine, Administration, Female, Least-squares analysis, Drug, Type 2, Glomerular Filtration Rate, Oral, Double-blind method, Diabetic nephropathies - urine, Glomerular filtration rate - drug effects, Hyperkalemia - epidemiology, Drug Administration Schedule, Dose-Response Relationship, Angiotensin Receptor Antagonists, 03 medical and health sciences, Double-Blind Method, Diabetic nephropathies - drug therapy, Diabetes Mellitus, Albuminuria, Humans, Naphthyridines, Least-Squares Analysis, Aged, Creatinine - urine, Analysis of Variance, Dose-Response Relationship, Drug, Angiotensin receptor antagonists - therapeutic use, Blood pressure - drug effects, Drug administration schedule, Naphthyridines - administration & dosage, ta3121, type 2 - ethnology, Naphthyridines - adverse effects, Diabetes Mellitus, Type 2, Hyperkalemia, Potassium, Medicine (all), Hyperkalemia - chemically induced, Albuminuria - drug therapy, type 2 - urine

Popis súboru: application/pdf

Prístupová URL adresa: https://jamanetwork.com/journals/jama/articlepdf/2432163/joi150099.pdf
https://pubmed.ncbi.nlm.nih.gov/26325557
http://hdl.handle.net/11588/659964
https://research.monash.edu/en/publications/effect-of-finerenone-on-albuminuria-in-patients-with-diabetic-nep
https://research.rug.nl/en/publications/effect-of-finerenone-on-albuminuria-in-patients-with-diabetic-nep
https://air.unimi.it/handle/2434/335378
https://www.ncbi.nlm.nih.gov/pubmed/26325557
https://jamanetwork.com/journals/jama/articlepdf/2432163/joi150099.pdf
https://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.10081
https://hdl.handle.net/11568/837948
https://doi.org/10.1001/jama.2015.10081
http://jama.jamanetwork.com/data/Journals/JAMA/934374/joi150099.pdf
https://hdl.handle.net/11588/659964